Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Versus Nalbuphine as an Adjuvant to Intrathecal Bupivacaine in Lower Limb Surgeries

NCT05347173 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05347173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05347173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Versus Nalbuphine as an Adjuvant to Intrathecal Bupivacaine in Lower Limb Surgeries
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Completed
Start date
June 21, 2022
Completion date
March 12, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia